8-KLeadership Changes

SOUTHERN CO 8-K Report, Executive Changes (Feb 13, 2018)

Filed February 13, 2018For Securities:SOSOJESOJFSOJCSOJDSOMN

Summary

Southern Company (SO) announced on February 12, 2018, the election of Dr. Ernest J. Moniz as a new director, effective March 1, 2018. This appointment brings a significant addition to the board with Dr. Moniz's extensive background in energy policy and national security, having previously served as the United States Secretary of Energy and holding leadership positions at the Nuclear Threat Initiative and Energy Futures Initiative. His expertise is expected to be a valuable asset to the company.

Key Highlights

  • 1Dr. Ernest J. Moniz elected as a new director, effective March 1, 2018.
  • 2Dr. Moniz appointed to the Nominating, Governance and Corporate Responsibility Committee.
  • 3Dr. Moniz appointed to the Operations, Environmental and Safety Committee.
  • 4Dr. Moniz appointed to the Business Security Subcommittee.
  • 5Dr. Moniz brings substantial experience as former U.S. Secretary of Energy.
  • 6Dr. Moniz currently serves as CEO of Nuclear Threat Initiative and Energy Futures Initiative.
  • 7Dr. Moniz will receive standard non-employee director compensation.

Frequently Asked Questions

Dr. Ernest J. Moniz is a distinguished figure in the energy sector, notably having served as the United States Secretary of Energy from 2013 to early 2017. His appointment to Southern Company's Board of Directors is significant due to his deep expertise in energy policy, nuclear security, and technological innovation, stemming from his leadership roles at the Nuclear Threat Initiative and Energy Futures Initiative, as well as his long tenure at MIT.

Effective March 1, 2018, Dr. Moniz will be a member of the Nominating, Governance and Corporate Responsibility Committee, the Operations, Environmental and Safety Committee, and the Business Security Subcommittee.

No, Dr. Moniz will participate in Southern Company's standard non-employee director compensation program, which includes both cash and equity components, as detailed in the company's April 7, 2017, Proxy Statement.

The filing states that there are no arrangements or understandings between Dr. Moniz and any other persons pursuant to which he was selected as a director, indicating a standard selection process.